Johnson & Johnson JNJ
266.69 USD -3.87 (-1.43%)
Nov 3, 2026, 3:25 PM EST
266.55 Day range 271.07
186.00 52-week range 278.43
- YTD
- +28.87%
- 1 year
- +43.18%
News
benzinga.com Jim Cramer Likes This Industrial Stock: ‘It's Come Down A Great Deal' On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Howmet Aerospace Inc. (NYSE:HWM) and recommended buying the same. “It's come down a great deal, and the numbers continue to be good,”…
benzinga.com Jim Cramer Likes This Industrial Stock: ‘It’s Come Down A Great Deal’ Cramer recommends Howmet and J&J, prefers Micron over Western Digital, criticizes Nebius, and favors Lam Research over KLA.
defenseworld.net Johnson & Johnson $JNJ Stake Boosted by Investment Partners LTD. Investment Partners LTD. boosted its holdings in Johnson and Johnson (NYSE: JNJ) by 115.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange…
defenseworld.net Johnson & Johnson $JNJ Stock Purchased by Hollow Brook Wealth Management LLC Hollow Brook Wealth Management LLC grew its stake in Johnson and Johnson (NYSE: JNJ) by 23.7% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 50,900 shares…
defenseworld.net 5,146 Johnson & Johnson $JNJ Shares Sold by Heritage Investors Management Corp Heritage Investors Management Corp reduced its position in shares of Johnson and Johnson (NYSE: JNJ) by 3.2% in the third quarter, according to its most recent 13F filing with the Securities and…
fool.com The Best Dividend Stocks to Buy With $5,000 in November AbbVie survived its loss of Humira, and its profits are soaring. J&J's streamlining efforts are paying off.
benzinga.com Growth And Cyclical Sectors Lead Monday Trading Seven sectors are higher and four are lower in Monday’s regular session, with growth and cyclical sectors splitting the top of the table. The leaders are separated rather than clustered, with no…
247wallst.com 2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold Forever Arthritis flares, cholesterol checks and cancer treatments arrive on their own schedule, in recessions and booms alike, which is why healthcare draws attention from retirees building an income plan.…
247wallst.com 3 Best Dividend Stocks for a $100,000 Passive Income Strategy Retirement flips the income question around. After decades of collecting a paycheck, retirees need assets that send cash on a predictable schedule, and that cash has to hold up when markets turn…
defenseworld.net 33,097 Johnson & Johnson $JNJ Shares Bought by International Assets Investment Management LLC International Assets Investment Management LLC raised its stake in Johnson and Johnson (NYSE: JNJ) by 195.8% in the third quarter, according to the company in its most recent filing with the…
defenseworld.net Gray Private Wealth LLC Acquires New Position in Johnson & Johnson $JNJ Gray Private Wealth LLC bought a new position in Johnson and Johnson (NYSE: JNJ) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
247wallst.com 4 Blue-Chip Dividend Stocks That Kept Raising Payouts Through 2008 and 2020 Some dividend stocks cut payouts the moment a recession hits, but a small group of blue chips kept raising theirs through the 2008 financial crisis and the 2020 shutdowns.
businesswire.com Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results SAN DIEGO--(BUSINESS WIRE)-- #PressRelease--Johnson & Johnson announced results from three clinical analyses being presented during the Transcatheter Cardiovascular Therapeutics annual scientific…
247wallst.com Suze Orman Says You Don’t Have to Buy Every Market Dip. Here’s Why Suze Orman says sitting still during a market sell-off is a legitimate strategy, but retirees paying bills from a falling portfolio rarely get that luxury. A specific kind of stock changes that…
247wallst.com Roth IRA vs. Taxable Account: How Much of $17,985 in Blue-Chip Dividends Would You Keep? A $600,000 portfolio spread across four blue-chip dividend legends generates a surprisingly large tax bill every year, and the difference between where you hold these shares could quietly reshape…
fool.com Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors. Johnson & Johnson is a large medical device and pharmaceutical company. Third-quarter 2026 earnings fell nearly 96% year over year.
247wallst.com No Tricks, Just Treats: 3 Dividend Stocks With Payouts You Can Trust Some dividend yields look generous right up until the moment they get cut, but a handful of companies have funded unbroken payout streaks through recessions, patent cliffs, and commodity shocks.…
zacks.com JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4? J&J's MedTech growth slows in Q3 amid international market challenges and Abiomed weakness.
247wallst.com No Tricks, Just Treats: 3 Dividend Stocks With Payouts You Can Trust On Halloween eve, the scariest thing an income investor can find is a yield that looks generous but is stressed. That is a payout the business can barely fund, and it tends to get cut at the worst…
247wallst.com 4 Dividend Kings With 50-Plus Years of Payout Increases for Retirement Income Four companies have raised their dividends every single year for at least half a century, but not all of them carry the same risks heading into retirement.
youtube.com The Big 3: AAPL, JNJ, MMM As a tech selloff sparked by Alphabet (GOOGL) earnings grips the stock market, Dan Deming continues to see the rotation as the biggest unsung headline for equities. As for today's Big 3, he expects…
247wallst.com Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher Merck (NYSE:MRK | MRK Price Prediction) is the second big drugmaker to reward investors with an earnings beat and a raised profit outlook.
zacks.com Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm…
247wallst.com VYM's Price May Be Soaring, but Its Dividend Isn't Keeping Up VYM has handed shareholders a remarkable run, but the gap between share price growth and dividend growth is raising an uncomfortable question for retirees counting on that quarterly check.
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson ("J&J" or the "Company") (NYSE: JNJ). Such investors are advised to contact…
benzinga.com Microsoft Goes Jumbo: $25 Billion Bond Sale in the Works Microsoft plans at least $25B in bonds, its first debt sale since 2017, to fund capital needs as AI-driven spending surges.
247wallst.com 4 Dividend-Paying Dow Jones Industrial Stocks That Beat Q3 Estimates Four blue-chip Dow dividend payers just topped Wall Street's third-quarter estimates, but their payout stories diverge sharply on yield, coverage, and growth. One just cut its quarterly check while…
seekingalpha.com Johnson & Johnson: Strong Q3 Growth, But 2027 Could Test Its Earnings Johnson & Johnson reported Q3 revenue of $25.4 billion, supported by Innovative Medicine's 7.9% operational growth, while MedTech lagged at 2.5%. Management raised its 2026 guidance and adjusted EPS.…
seekingalpha.com Best Dividend Aristocrats For November 2026 Dividend Aristocrats underperformed SPY in September but rebounded sharply in October, narrowing the YTD gap. NOBL and the average Aristocrat have YTD returns of 13.13% and 13.35%, trailing SPY's…
benzinga.com Cyclicals Lead Sectors In Wednesday Trading As Real Estate Trails Four sectors are higher and seven are lower in Wednesday’s regular session, with cyclical and defensive sectors split at the top of the table. The leaders are separated rather than clustered, with…
247wallst.com Why JEPI’s Total Return Has Outpaced Its Payout JEPI's share price keeps climbing while its monthly cash payments quietly shrink, and the reason behind that split reveals something most income investors never check before buying a covered-call…
defenseworld.net Johnson & Johnson $JNJ Stock: Bernardo Wealth Planning LLC Raises Holdings Bernardo Wealth Planning LLC boosted its position in shares of Johnson and Johnson (NYSE: JNJ) by 105.8% during the undefined quarter, according to its most recent Form 13F filing with the Securities…
defenseworld.net 29,241 Shares of Johnson & Johnson $JNJ Acquired by BG Investment Services LLC BG Investment Services LLC acquired a new position in shares of Johnson and Johnson (NYSE: JNJ) during the third quarter, according to the company in its most recent Form 13F filing with the…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson (“J&J” or the “Company”) (NYSE: JNJ). Such investors are advised to…
247wallst.com Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks Medtronic's 49-year dividend streak sounds impressive until you meet the two medical device rivals that have been raising payouts even longer, and the differences in yield, valuation, and balance…
zacks.com 4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential LLY, NVS, JNJ and ABBV offer arthritis drug growth potential through rising sales, regulatory approvals and clinical advances across inflammatory joint diseases.
247wallst.com $200,000 in Dividend Stocks: How Much More Could You Keep in a Roth IRA? Parking six popular dividend stocks in a taxable account quietly hands the IRS a cut of every payout, and one holding in your portfolio is almost certainly the biggest culprit.
247wallst.com CDs or Dividend Stocks: Which Pays Retirees Better Right Now? Johnson and Johnson, Procter and Gamble, and Coca-Cola all beat the national CD average on yield, but the real comparison has nothing to do with today's rate and everything to do with what happens to…
benzinga.com Johnson & Johnson Plans To Hold Enterprise Business Review On Dec. 8 Johnson & Johnson (NYSE: JNJ) will hold an Enterprise Business Review for the investment community on Tuesday, December 8th, 2026. During the event, Company leaders will provide a detailed review of…
businesswire.com Johnson & Johnson to Host Enterprise Business Review NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will hold an Enterprise Business Review for the investment community on Tuesday, December 8th, 2026. During the event, Company…
defenseworld.net Fifth Third Wealth Advisors LLC Purchases 2,845 Shares of Johnson & Johnson $JNJ Fifth Third Wealth Advisors LLC lifted its position in Johnson and Johnson (NYSE: JNJ) by 4.9% in the undefined quarter, according to the company in its most recent filing with the Securities and…
defenseworld.net Barrett & Company Inc. Acquires 50,741 Shares of Johnson & Johnson $JNJ Barrett and Company Inc. boosted its stake in Johnson and Johnson (NYSE: JNJ) by 531.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission…
benzinga.com Nasdaq Gains Over 200 Points As Chip Stocks Rise: Investor Sentiment Improves, Fear & Greed Index Moves to ‘Fear’ Zone U.S. stocks rose Monday as AI shares gained, but CNN’s Fear & Greed Index remained in the Fear zone at 27. Investors await major earnings.
benzinga.com Coca-Cola, Boeing and 3 Stocks to Watch Heading Into Tuesday Stocks in focus: Coca-Cola and Boeing report earnings; Whirlpool cuts guidance after a miss, while Celestica beats estimates and raises outlook.
benzinga.com Mark Cuban Warns CEOs If Your Health Benefits Do Not Actually Help Employees You Are Legally Liable - 'It’s All On You’ Billionaire entrepreneur Mark Cuban says company leaders who treat employee health benefits as someone else's problem may be setting themselves up for a legal reckoning, and he wants them to know it.
benzinga.com Meta Tumbles 6% on AI Spending Fears, 10-Year Yield Falls Below 5%: Stock Market Today Meta's higher AI spending plan drags tech lower as Treasurys rally and the 10-year yield drops below 5%. Gold, silver and Bitcoin fall; oil climbs.
benzinga.com Defensives Lead Sectors In Thursday Trading As Growth Trails Five sectors are higher and six are lower in Thursday’s regular session, with defensive sectors holding the top three positions. The leaders are separated rather than clustered, with no single gap…- benzinga.com Johnson & Johnson Announces Data From Its VARIPURE, Omny-IRE Trials Demonstrated 100% Of Participants Had Acute Procedural Success; Mean Ablation Rate Of 17.9 Minutes Observed Johnson & Johnson (NYSE: JNJ) today announced new data from the late-breaking VARIPURE and Omny-IRE studies presented at the Asia Pacific Heart Rhythm Society (APHRS) 2026 Annual Meeting in Busan,…
benzinga.com Cyclicals Top Sectors In Wednesday Trading As Defensives Trail Five sectors are higher and six are lower in Wednesday’s regular session, with cyclical sectors holding two of the top three positions alongside Technology. The leaders are separated rather than…
benzinga.com Johnson & Johnson Announces 1-Yr Results From Phase 3 FUZION Study Showing TREMFYA Maintained Or Improved Fistula Remission Through 48 Weeks In Adults With Crohn's Disease TREMFYA maintained combined fistula remission through Week 48 across both maintenance dose regimens, including an increase from 28% at Week 24 to 35% at Week 48 in the 100 mg dose groupThese findings…